If you need more lookups,
subscriptions start at $34 USD/month.
Gregory Fanning Location
France
Gregory Fanning Work
2022 -now Chief Business Officer @
2023 -now Advisor @
2022 -now Advisor - Therapeutic application and strategy for RNA and biomolecule stabilisation platform @
2019 -now Advisor @ CommBio Therapeutics
2019 -now Advisor - Scientific and Business Strategy @
2019 -now Biotech Advisor and Consultant @ Si3
2018 -2019 HBV Innovation Leader, China. @
2015 -2019 Head of China Discovery Centre @
2005 -2015 Senior Scientific Director @
1999 -2005 Senior Scientist @
Gregory Fanning Education
University of Oxford
DPhil (Genetics, Immunology)
1995-1999
Gregory Fanning Skills
Drug Discovery
Life Sciences
Pharmaceutical Industry
Infectious Diseases
Drug Development
Immunology
Biotechnology
Research and Development (R&D)
Pharmaceutical Research
Decision-Making
Strategy
Talent Development
Organizational Leadership
Due Diligence
competitive intelligence
healthcare analyst
Communication excellence
Medical writing
Project ideation and delivery
Stakeholder Management
Clinical Development
R&D
Technology Transfer
Virology
Gregory Fanning Summary
Gregory Fanning, based in France, is currently a Chief Business Officer at AstriVax. Gregory Fanning brings experience from previous roles at ExeVir, RNAssist, CommBio Therapeutics and SCG Cell Therapy. Gregory Fanning holds a 1995 - 1999 DPhil in Genetics, Immunology @ University of Oxford. With a robust skill set that includes Drug Discovery, Life Sciences, Pharmaceutical Industry, Infectious Diseases, Drug Development and more. Gregory Fanning has 3 emails on RocketReach.
Looking for a different Gregory Fanning?
Find contact details for 700 million professionals.